PH31676A - Compounds compositions and methods for binding bio-affecting subtances to surface membranes of bio-particles. - Google Patents
Compounds compositions and methods for binding bio-affecting subtances to surface membranes of bio-particles.Info
- Publication number
- PH31676A PH31676A PH45327A PH45327A PH31676A PH 31676 A PH31676 A PH 31676A PH 45327 A PH45327 A PH 45327A PH 45327 A PH45327 A PH 45327A PH 31676 A PH31676 A PH 31676A
- Authority
- PH
- Philippines
- Prior art keywords
- bio
- subtances
- affecting
- particles
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1258—Pills, tablets, lozenges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Indole Compounds (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79893691A | 1991-11-27 | 1991-11-27 | |
US07/884,432 US5667764A (en) | 1988-05-02 | 1992-05-15 | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
Publications (1)
Publication Number | Publication Date |
---|---|
PH31676A true PH31676A (en) | 1999-01-18 |
Family
ID=27122052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH45327A PH31676A (en) | 1991-11-27 | 1992-11-26 | Compounds compositions and methods for binding bio-affecting subtances to surface membranes of bio-particles. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0643706A1 (zh) |
JP (2) | JP3682974B2 (zh) |
CN (1) | CN1074911A (zh) |
AU (2) | AU3221993A (zh) |
CA (1) | CA2124329C (zh) |
IL (1) | IL103874A0 (zh) |
MX (1) | MX9206844A (zh) |
NZ (1) | NZ245271A (zh) |
PH (1) | PH31676A (zh) |
WO (1) | WO1993011120A1 (zh) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0706376B2 (en) * | 1993-07-19 | 2007-08-08 | Angiotech Pharmaceuticals, Inc. | Anti-angiogenic compositions and methods of use |
DK1118325T4 (da) * | 1993-07-29 | 2010-04-06 | Us Health | Anvendelse af paclitaxel og dets derivater ved fremstilling af et medikament til behandling af restenose |
US5480901A (en) * | 1994-10-07 | 1996-01-02 | Zynaxis, Inc. | Method for reducing unwanted cellular adhesions |
US6492332B1 (en) | 1995-12-12 | 2002-12-10 | Omeros Corporation | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation |
US6004536A (en) * | 1995-11-14 | 1999-12-21 | Molecular Probes, Inc. | Lipophilic cyanine dyes with enchanced aqueous solubilty |
WO1997024459A1 (en) * | 1995-12-29 | 1997-07-10 | Phanos Technologoes, Inc. | Method for reducing unwanted cellular adhesions |
US5871436A (en) * | 1996-07-19 | 1999-02-16 | Advanced Cardiovascular Systems, Inc. | Radiation therapy method and device |
US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
EP1512398A1 (en) * | 1997-03-31 | 2005-03-09 | Boston Scientific Limited | Intravascular stent with cytoskeletal inhibitors for the prevention of restenosis |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US20040254635A1 (en) | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US7045305B1 (en) * | 1998-04-08 | 2006-05-16 | The Regents Of The University Of California | Methods and reagents for targeting organic compounds to selected cellular locations |
US6120847A (en) * | 1999-01-08 | 2000-09-19 | Scimed Life Systems, Inc. | Surface treatment method for stent coating |
US6333347B1 (en) | 1999-01-29 | 2001-12-25 | Angiotech Pharmaceuticals & Advanced Research Tech | Intrapericardial delivery of anti-microtubule agents |
US6419692B1 (en) | 1999-02-03 | 2002-07-16 | Scimed Life Systems, Inc. | Surface protection method for stents and balloon catheters for drug delivery |
US6156373A (en) * | 1999-05-03 | 2000-12-05 | Scimed Life Systems, Inc. | Medical device coating methods and devices |
EP1218570A1 (en) * | 1999-08-23 | 2002-07-03 | Angiogene, Inc. | Radioactively coated device and method of making same for preventing restenosis |
CO5261573A1 (es) | 1999-11-19 | 2003-03-31 | Novartis Ag | Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion |
IT1319168B1 (it) * | 2000-03-17 | 2003-09-26 | Indena Spa | Derivati di condensazione ad attivita' antitumorale, loro metodo dipreparazione e formulazioni che li contengono. |
CA2424305A1 (en) | 2000-10-16 | 2002-04-25 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
US7776529B2 (en) | 2003-12-05 | 2010-08-17 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
EP1814598B1 (en) | 2004-11-22 | 2011-01-12 | Ge Healthcare As | Contrast agents to target extracellular matrix |
US9050393B2 (en) | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
US7598390B2 (en) | 2005-05-11 | 2009-10-06 | Life Technologies Corporation | Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use |
US8114429B2 (en) | 2008-09-15 | 2012-02-14 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US8257722B2 (en) | 2008-09-15 | 2012-09-04 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9198968B2 (en) | 2008-09-15 | 2015-12-01 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9956385B2 (en) | 2012-06-28 | 2018-05-01 | The Spectranetics Corporation | Post-processing of a medical device to control morphology and mechanical properties |
JP6510422B2 (ja) * | 2013-11-26 | 2019-05-08 | 住友化学株式会社 | ゴム組成物及び加硫助剤 |
US10525171B2 (en) | 2014-01-24 | 2020-01-07 | The Spectranetics Corporation | Coatings for medical devices |
EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
KR102464647B1 (ko) | 2016-11-28 | 2022-11-08 | 바이엘 파마 악티엔게젤샤프트 | 자기 공명 영상화에 사용하기 위한 높은 이완도 가돌리늄 킬레이트 화합물 |
BR112021007707A2 (pt) | 2018-11-23 | 2021-07-27 | Bayer Aktiengesellschaft | formulação de meios de contraste e processo de preparação da mesma |
JP7423888B2 (ja) * | 2019-11-22 | 2024-01-30 | 株式会社同仁化学研究所 | 脂質二分子膜染色用色素及びそれを用いた脂質二分子膜の染色方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
EP0047470B1 (en) * | 1980-09-02 | 1985-04-24 | Fuji Photo Film Co., Ltd. | Method for immunochemical measurement |
US4501728A (en) * | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US4751219A (en) * | 1985-02-05 | 1988-06-14 | Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek | Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides |
US4762701A (en) * | 1986-10-31 | 1988-08-09 | Smithkline Beckman Corporation | In vivo cellular tracking |
US4783401A (en) * | 1986-10-31 | 1988-11-08 | Smithkline Beckman Corporation | Viable cell labelling |
US4906749A (en) * | 1987-06-30 | 1990-03-06 | Viomedics Inc. | Cyclic anhydride derivatives of chromophors |
WO1989006654A1 (en) * | 1988-01-19 | 1989-07-27 | Board Of Regents, The University Of Texas System | Glycosides, liposomal compositions thereof, and methods for their use |
DE68927479T2 (de) * | 1988-05-02 | 1997-04-03 | Phanos Tech Inc | Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen |
US5149794A (en) * | 1990-11-01 | 1992-09-22 | State Of Oregon | Covalent lipid-drug conjugates for drug targeting |
-
1992
- 1992-11-24 EP EP93900600A patent/EP0643706A1/en not_active Withdrawn
- 1992-11-24 CA CA002124329A patent/CA2124329C/en not_active Expired - Lifetime
- 1992-11-24 JP JP51019093A patent/JP3682974B2/ja not_active Expired - Lifetime
- 1992-11-24 WO PCT/US1992/010076 patent/WO1993011120A1/en not_active Application Discontinuation
- 1992-11-24 AU AU32219/93A patent/AU3221993A/en not_active Abandoned
- 1992-11-25 IL IL103874A patent/IL103874A0/xx unknown
- 1992-11-25 NZ NZ245271A patent/NZ245271A/en unknown
- 1992-11-26 PH PH45327A patent/PH31676A/en unknown
- 1992-11-26 CN CN92115176A patent/CN1074911A/zh active Pending
- 1992-11-27 MX MX9206844A patent/MX9206844A/es unknown
-
1997
- 1997-04-30 AU AU19914/97A patent/AU1991497A/en not_active Abandoned
-
2002
- 2002-07-01 JP JP2002192417A patent/JP4095847B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH08502719A (ja) | 1996-03-26 |
CA2124329C (en) | 2008-11-18 |
EP0643706A4 (en) | 1994-12-27 |
JP4095847B2 (ja) | 2008-06-04 |
WO1993011120A1 (en) | 1993-06-10 |
NZ245271A (en) | 1996-03-26 |
IL103874A0 (en) | 1993-04-04 |
AU1991497A (en) | 1997-07-10 |
JP2003026657A (ja) | 2003-01-29 |
CA2124329A1 (en) | 1993-06-10 |
AU3221993A (en) | 1993-06-28 |
EP0643706A1 (en) | 1995-03-22 |
MX9206844A (es) | 1993-07-01 |
CN1074911A (zh) | 1993-08-04 |
JP3682974B2 (ja) | 2005-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH31676A (en) | Compounds compositions and methods for binding bio-affecting subtances to surface membranes of bio-particles. | |
HK1001665A1 (en) | Unpleasant taste masking compositions and methods for preparing same | |
HK1007108A1 (en) | Compositions and methods for the controlled release of soluble active substances | |
IL104007A0 (en) | Adhesive composition and method of using it | |
GB2219937B (en) | Composition for desorbing bacteria | |
LTIP249A (en) | Pharmaceutical composition and process for the preparation thereof | |
GB9108369D0 (en) | Compositions of matter | |
EP0448128A3 (en) | Cembrane-type diterpene compounds for use in the production of compositions containing histamine release inhibitors | |
HU895450D0 (en) | Process for the preparation of antiflatulent pharmaceutical composition containing activated polydimethylsiloxane in solid dispersion | |
DE59209864D1 (de) | Verfahren zur Herstellung von in 3-Stellung substituierten 4-Cyano-pyrrolverbindungen | |
ZA929179B (en) | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles. | |
GB8821183D0 (en) | Composition of matter | |
EP0437367A3 (en) | Compositions and methods for inhibiting osteoclast cellular adhesion to bone | |
JPS6426633A (en) | Alkoxylated polyester and its production and composition containing said polyester as effective component | |
ZA939155B (en) | Substituted N-hydroxycinnamamides processes for their preparation compositions containing them and their use | |
ZA957322B (en) | Tetrahydropyran compounds process for the preparation thereof and pharmaceutical compositions containing them | |
EP0642354A4 (en) | METHODS FOR DETECTING AND ISOLATING uPA-R AND INHIBITING THE BINDING OF uPA TO uPA-R. | |
DE69304982T2 (de) | Buchbindungsverfahren und Klebstoffzusammensetzung zur Durchführung des Verfahrens | |
IE891338L (en) | Compounds for binding bio-affecting substances to surface¹membranes of bio-particles | |
EP0508119A3 (en) | Novel process for the preparation of amine-terminated compounds | |
GB8712396D0 (en) | Composition of matter | |
IL72451A (en) | Pharmaceutical antitumor composition containing rhizoxin and method for the preparation thereof | |
LTIP164A (en) | Composition of extract | |
PL289404A1 (en) | Method of isolating alkaloids as individual compounds or in groups from materials of plant origin | |
DE3468674D1 (en) | Polycyclic alcohol, process for its preparation, its use as smelling ingredient, and composition containing it |